|
Index of reports
> Cases resulting in disability (19)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in disability.
Adverse event in 44 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-10-11
Patient: 44 year old male
Adverse reactions / side effects: Optic Atrophy, Glaucoma, Optic Nerve Disorder, Drug Ineffective, Tooth Abscess, Trigeminal Neuralgia, Sciatica, Tooth Extraction, Visual Acuity Reduced, Treatment Noncompliance, Balance Disorder, Leukoencephalopathy, Depression, Optic Neuritis Retrobulbar, Facial Pain, Mononeuropathy Multiplex, Visual Disturbance, Gastrointestinal Disorder, Memory Impairment, Neuralgia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Retrovir
Indication: HIV Infection
Start date: 2006-06-23
Telzir
Indication: HIV Infection
Start date: 2005-03-29
End date: 2006-06-23
Combivir
Indication: HIV Infection
Start date: 2005-09-28
End date: 2006-06-23
Epivir
Indication: HIV Infection
Start date: 1998-04-01
Viread
Indication: HIV Infection
Start date: 2006-06-23
Invirase
Indication: HIV Infection
Start date: 2006-06-23
Lyrica
Indication: Trigeminal Neuralgia
Start date: 2006-06-23
End date: 2006-07-01
Neurontin
Indication: Trigeminal Neuralgia
Start date: 2006-01-01
End date: 2006-01-01
Bactrim
Start date: 1998-09-01
Norvir
Indication: HIV Infection
Start date: 2004-04-17
Other drugs received by patient: Viracept; Zerit
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-05
Patient: 49 year old male
Adverse reactions / side effects: Diabetes Mellitus
Adverse event resulted in: disablity
Suspect drug(s):
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-03-05
End date: 2004-01-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1997-11-01
End date: 2005-11-28
Other drugs received by patient: Viracept; Novact M; Baktar; Crixivan; Zantac; Urinorm
Adverse event in 42 year old male receiving Epivir (Lamivudine)
Reported by a physician from Germany on 2007-06-19
Patient: 42 year old male, weighing 75.7 kg (166.5 pounds)
Adverse reactions / side effects: Pruritus, Urticaria, Hepatic Steatosis, Lipohypertrophy, Lipomatosis, Lipodystrophy Acquired, FAT Redistribution, Hepatosplenomegaly
Adverse event resulted in: disablity
Suspect drug(s):
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 1999-07-15
End date: 2005-10-24
Combivir
Dosage: 450mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 1997-04-11
End date: 2005-10-24
Retrovir
Dosage: 250mg twice per day
Administration route: Oral
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Other drugs received by patient: Multiple Medication; Crixivan; Efavirenz; Tenofovir; Peginterferon Alfa-2A; Ribavirin
Adverse event in 42 year old male receiving Epivir (Lamivudine)
Reported by a physician from Germany on 2007-06-18
Patient: 42 year old male, weighing 75.7 kg (166.5 pounds)
Adverse reactions / side effects: Pruritus, Urticaria, Hepatic Steatosis, Lipohypertrophy, Lipomatosis, Lipodystrophy Acquired, FAT Redistribution, Hepatosplenomegaly
Adverse event resulted in: disablity
Suspect drug(s):
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 1999-07-15
End date: 2005-10-24
Combivir
Dosage: 450mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 1997-04-11
End date: 2005-10-24
Retrovir
Dosage: 250mg twice per day
Administration route: Oral
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Other drugs received by patient: Multiple Medication; Crixivan; Efavirenz; Tenofovir; Peginterferon Alfa-2A; Ribavirin
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Palpitations, Dizziness
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1994-11-19
Efavirenz
Dosage: therapy stopped on 25-jul-2000, restarted on 25-sep-2000.
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-10-02
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2001-10-20
Indinivir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-08
End date: 2000-05-24
Ziagen
Dosage: therapy stopped on 25-jul-2000, restarted on 20-oct-2001.
Administration route: Oral
Start date: 2000-07-24
End date: 2001-10-27
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
Ritonavir
Dosage: therapy stopped on 24-dec-2000, restarted on 01-apr-2005.
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Lopinavir + Ritonavir
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Other drugs received by patient: Factor Viii
Adverse event in 24 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-06-05
Patient: 24 year old male
Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea, Palpitations, Asthenia, Pulmonary Artery Dilatation, Cardiomegaly
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
Norvir
Administration route: Oral
Start date: 2004-04-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Stocrin
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 2001-07-21
Zerit
Administration route: Oral
Start date: 1997-08-25
End date: 2001-10-20
Crixivan
Dosage: 800mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Invirase
Dosage: 800mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Other drugs received by patient: Reyataz; Viread; Anti-Hemophilic Globulin; Ziagen
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-05-22
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-06-01
End date: 2003-09-22
Epivir
Dosage: 300mg per day
Administration route: Oral
Start date: 2005-05-23
End date: 2005-07-25
Epivir
Dosage: 150mg per day
Administration route: Oral
Start date: 2005-11-29
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Ziagen; Norvir; Reyataz; Baktar
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-22
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-29
Epivir
Dosage: 05-may-05 to 25-jul-05, restarted on 29-nov-05 to unknown
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Baktar; Ziagen; Norvir
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-04-30
Patient: 49 year old male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Disorientation, Hepatitis, Amnesia, Somnolence, Neuropathy Peripheral, Fatigue, Visual Disturbance, Balance Disorder, Chest Pain, Pancreatitis, Myocardial Infarction, Hypertension
Adverse event resulted in: disablity
Suspect drug(s):
Zerit
Dosage: therapy start date: 1997 or 1998
Indication: HIV Infection
End date: 2003-08-01
Videx
Dosage: therapy start date: 1997 or 1998
Indication: HIV Infection
Viracept
Dosage: therapy start date: 1997 or 1998
Indication: HIV Infection
Epivir
Indication: HIV Infection
Viread
Indication: HIV Infection
Other drugs received by patient: Centrum
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-03-30
Patient: male
Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-09-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-10-18
Predonine
Indication: Drug Eruption
Start date: 2004-09-23
End date: 2004-09-26
Other drugs received by patient: Clarithromycin; Baktar
Adverse event in 31 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-28
Patient: 31 year old male
Adverse reactions / side effects: Renal Impairment, Schizophrenia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2003-03-28
End date: 2004-05-27
Epivir
Dosage: dosing began 20-apr-05. interrupted 27-may-2004. restarted 20-apr-2005. discontinued 13-jun-2005.
Administration route: Oral
Indication: HIV Infection
Start date: 2003-03-28
End date: 2005-06-13
Retrovir
Dosage: decreased to 400 mg od, from 06-may-03 to 27-may-04.
Administration route: Oral
Indication: HIV Infection
Start date: 2003-03-28
End date: 2004-05-27
Other drugs received by patient: Penfill
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-03-22
Patient: male
Adverse reactions / side effects: Nephritis Interstitial, Nephrotic Syndrome
Adverse event resulted in: disablity
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-28
End date: 2004-01-13
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-28
End date: 2004-09-24
Kaletra
Administration route: Oral
Start date: 2001-10-22
End date: 2002-03-11
Ziagen
Administration route: Oral
Indication: HIV Infection
Start date: 2001-10-22
End date: 2002-03-11
Ziagen
Administration route: Oral
Start date: 2002-03-28
End date: 2004-11-03
Ziagen
Administration route: Oral
Start date: 2005-03-18
Diflucan
Indication: Oral Candidiasis
Start date: 2002-07-24
Viracept
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-06
End date: 2001-10-21
Viracept
Administration route: Oral
Start date: 2004-09-27
End date: 2004-11-03
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-06
End date: 2001-10-21
Epivir
Administration route: Oral
Start date: 2004-09-27
End date: 2004-11-03
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-06
End date: 2002-03-11
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-10
End date: 2004-09-14
PEG-Intron
Dosage: 100 micro g/kg
Indication: Hepatitis C
Start date: 2004-12-13
End date: 2005-01-17
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2004-12-13
End date: 2005-01-14
Ribavirin
Administration route: Oral
Start date: 2005-01-15
End date: 2005-01-17
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-02-16
Stocrin
Administration route: Oral
Indication: HIV Infection
Start date: 2005-02-16
End date: 2005-03-28
Lexiva
Administration route: Oral
Indication: HIV Infection
Start date: 2005-02-16
Epzicom
Indication: HIV Infection
Start date: 2005-02-16
End date: 2005-03-17
Other drugs received by patient: Loxonin
Adverse event in 36 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-03-21
Patient: 36 year old male
Adverse reactions / side effects: Abdominal Pain, Productive Cough, Protein Urine Present, Dyspnoea, Metabolic Acidosis, Pain, Nephrotic Syndrome, Nephritis Interstitial, Diarrhoea, Oedema Peripheral, Hypoalbuminaemia, Cough
Adverse event resulted in: disablity
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2001-08-06
End date: 2004-11-03
Ziagen
Administration route: Oral
Indication: HIV Infection
Start date: 2001-01-22
Viracept
Dosage: 2500mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-11-03
Kaletra
Dosage: 6cap per day
Administration route: Oral
Indication: HIV Infection
Start date: 2001-10-22
Atazanavir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-16
End date: 2004-09-24
Tenofovir Disoproxil Fumarate
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2002-04-01
End date: 2004-01-13
Ribavirin
Administration route: Oral
Interferon Alfa-2B
Start date: 2004-12-27
Other drugs received by patient: Diflucan; Loxonin; Urinorm
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-02-26
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-29
Epivir
Dosage: 05-may-05 to 25-jul-05, restarted on 29-nov-05 to unknown
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Baktar; Ziagen; Norvir
Adverse event in 74 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-02-19
Patient: 74 year old male
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: disablity
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2003-06-01
End date: 2003-09-22
Epivir
Dosage: 300mg per day
Administration route: Oral
Start date: 2005-05-23
End date: 2005-07-25
Epivir
Dosage: 150mg per day
Administration route: Oral
Start date: 2005-11-29
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-29
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
End date: 2005-07-25
Other drugs received by patient: Ziagen; Norvir; Baktar
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-02-16
Patient: male
Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-09-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-10-18
Predonine
Indication: Drug Eruption
Start date: 2004-09-23
End date: 2004-09-26
Other drugs received by patient: Clarithromycin; Baktar
Adverse event in male receiving Epivir (Lamivudine)
Reported by a physician from United States on 2007-02-15
Patient: male
Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy
Adverse event resulted in: disablity
Suspect drug(s):
Efavirenz
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Zerit
Start date: 2005-02-23
End date: 2005-12-29
Epivir
Start date: 2005-02-23
Viramune
Start date: 2005-12-29
Retrovir
Start date: 2005-12-29
Other drugs received by patient: Bactrim; Vitamin B Complex CAP
Adverse event in male receiving Epivir (Lamivudine)
Reported by a physician from United States on 2007-02-09
Patient: male
Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy
Adverse event resulted in: disablity
Suspect drug(s):
Efavirenz
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Zerit
Start date: 2005-02-23
End date: 2005-12-29
Epivir
Start date: 2005-02-23
Viramune
Start date: 2005-12-29
Retrovir
Start date: 2005-12-29
Other drugs received by patient: Bactrim; Vitamin B Complex CAP
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-01-22
Patient: male
Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-09-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-13
End date: 2004-10-18
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-27
End date: 2004-10-18
Predonine
Indication: Drug Eruption
Start date: 2004-09-23
End date: 2004-09-26
Other drugs received by patient: Clarithromycin; Bactrim
|
